Immunogenicity and Safety Results of a Randomized, Three-Arm, Phase IV Clinical Trial of Concomitant Administration of Typhoid Vi Conjugate Vaccine with Measles and Rubella Vaccine in Healthy Infants. [PDF]
Rao SN +21 more
europepmc +1 more source
[On the mass of microbic substance in typhoid-paratyphoid vaccine].
V L, TROICKY, R A, WEGER
openaire +1 more source
False positive results in the Widal test in adults immunized with the Commirnaty (Pfizer-BioNtech) and BBIBP-CorV (Sinopharm) vaccines against COVID-19. [PDF]
Moya-Salazar J +5 more
europepmc +1 more source
[ALUMINUM HYDROXIDE AS AN ADSORBENT FOR TYPHOID-PARATYPHOID VACCINES].
W, WOJCIAK, E, WOLSKA
openaire +1 more source
Emergence of Azithromycin-resistant Salmonella Typhi in Southeast Asia: A systematic review. [PDF]
Zaffar S, Sadiqa A.
europepmc +1 more source
Current status of vaccine clinical trials registered on China's Drug Trial Registration and information disclosure platform, 2013-2024. [PDF]
Zhong S, Lin Z, Li J, Xie F, Zhang D.
europepmc +1 more source
Typhoid & paratyphoid vaccine development in the laboratory: a review & in-country experience. [PDF]
Chakraborty S, Das S.
europepmc +1 more source
Safety and Immunogenicity of Salmonella typhi Ty21a Liquid Formulation Vaccine in 4- to 6-Year-Old Thai Children [PDF]
Cryz, S. J. +4 more
core

